OTCMKTS:PSID

PositiveID Stock Forecast, Price & News

$0.0001
0.00 (-50.00 %)
(As of 03/26/2020)
Add
Compare
Today's Range
$0.00
$0.00
50-Day Range N/A
52-Week Range
$0.00
$0.00
Volume32.70 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive PSID News and Ratings via Email

Sign-up to receive the latest news and ratings for PositiveID and its competitors with MarketBeat's FREE daily newsletter.


About PositiveID

PositiveID Corporation, a life sciences and technology company, develops and sells molecular diagnostic systems for bio-threat detection and medical testing in the United States and internationally. It operates through three segments: Molecular Diagnostics, Medical Devices, and Mobile Labs. The company develops microfluidic systems for the automated preparation and performance of biological assays to detect biological threats and analyze biological samples at the point of need. It has a portfolio of intellectual property related to sample preparation and rapid medical testing applications. The company's microfluidic bio-agent autonomous networked detector (M-BAND) technology is a bio-aerosol monitor with integrated systems for sample collection, processing, and detection modules. Its M-BAND technology analyzes air samples for the detection of pathogenic bacteria, viruses, and toxins for up to 30 days. The company's FireflyDX is an automated pathogen detection system for rapid diagnostics for clinical and point-of-need applications. Its FireflyDX system detects and identifies common pathogens and diseases, such as E. coli, methicillin-resistant staphylococcus aureus, methicillin-susceptible staphylococcus aureus, clostridium difficile, Zika virus, Ebola virus, influenza, and others. In addition, PositiveID Corporation markets Caregiver, a non-contact clinical thermometer that measures forehead temperature in adults, children, and infants for hospitals, physicians' offices, medical clinics, nursing homes and other long-term care institutions, and acute care hospitals; and manufactures and sells specialty technology vehicles for mobile laboratory, command and communications applications, and mobile cellular systems. The company was formerly known as VeriChip Corporation and changed its name to PositiveID Corporation in November 2009. PositiveID Corporation was founded in 2001 and is headquartered in Delray Beach, Florida.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.69 out of 5 stars

Medical Sector

1335th out of 2,100 stocks

Analytical Instruments Industry

24th out of 32 stocks

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











PositiveID (OTCMKTS:PSID) Frequently Asked Questions

What stocks does MarketBeat like better than PositiveID?

Wall Street analysts have given PositiveID a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but PositiveID wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has PositiveID's stock been impacted by COVID-19?

PositiveID's stock was trading at $0.0002 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, PSID stock has decreased by 50.0% and is now trading at $0.0001.
View which stocks have been most impacted by COVID-19
.

Who are PositiveID's key executives?

PositiveID's management team includes the following people:
  • Mr. William J. Caragol, Chairman, CEO & Acting CFO (Age 52)
  • Mr. Gary J. O'Hara, Chief Technology Officer (Age 69)
  • Ms. Allison F. Tomek, Sr. VP of Corp. Devel. & Sec.
  • Dr. Kimothy Smith Ph.D., Chief Technology Advisor & Member of Advisory Board

Who are some of PositiveID's key competitors?

What other stocks do shareholders of PositiveID own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PositiveID investors own include Vuzix (VUZI), Marijuana Company of America (MCOA), Bridgeline Digital (BLIN), InterCloud Systems (ICLD), Inpixon (INPX), DICK'S Sporting Goods (DKS), Precipio (PRPO), Amarin (AMRN), Biocept (BIOC) and HealthEquity (HQY).

What is PositiveID's stock symbol?

PositiveID trades on the OTCMKTS under the ticker symbol "PSID."

How do I buy shares of PositiveID?

Shares of PSID can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PositiveID's stock price today?

One share of PSID stock can currently be purchased for approximately $0.00.

How many employees does PositiveID have?

PositiveID employs 30 workers across the globe.

What is PositiveID's official website?

The official website for PositiveID is www.psidcorp.com.

Where are PositiveID's headquarters?

PositiveID is headquartered at 1690 SOUTH CONGRESS AVENUE SUITE 201, DELRAY BEACH FL, 33445.

How can I contact PositiveID?

PositiveID's mailing address is 1690 SOUTH CONGRESS AVENUE SUITE 201, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-805-8000.


This page was last updated on 6/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.